These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Pneumococcal vaccines. Ho CF; Lin TY Chang Gung Med J; 2005 Nov; 28(11):765-72. PubMed ID: 16422182 [TBL] [Abstract][Full Text] [Related]
30. Vaccine Failures in Patients Properly Vaccinated with 13-Valent Pneumococcal Conjugate Vaccine in Catalonia, a Region with Low Vaccination Coverage. Moraga-Llop F; Garcia-Garcia JJ; Díaz-Conradi A; Ciruela P; Martínez-Osorio J; González-Peris S; Hernández S; de Sevilla MF; Uriona S; Izquierdo C; Selva L; Campins M; Codina G; Batalla J; Esteva C; Domínguez À; Muñoz-Almagro C Pediatr Infect Dis J; 2016 Apr; 35(4):460-3. PubMed ID: 26658626 [TBL] [Abstract][Full Text] [Related]
31. Introduction of pneumococcal conjugate vaccine into the public immunization program in South Africa: translating research into policy. Madhi SA; Cohen C; von Gottberg A Vaccine; 2012 Sep; 30 Suppl 3():C21-7. PubMed ID: 22939016 [TBL] [Abstract][Full Text] [Related]
32. Challenges in the evaluation and licensing of new pneumococcal vaccines, 7-8 July 2008, Ottawa, Canada. Feavers I; Knezevic I; Powell M; Griffiths E; Vaccine; 2009 Jun; 27(28):3681-8. PubMed ID: 19442421 [TBL] [Abstract][Full Text] [Related]
33. Advances in pneumococcal vaccines: the 13-valent pneumococcal conjugate vaccine received market authorization in Europe. Reinert RR; Paradiso P; Fritzell B Expert Rev Vaccines; 2010 Mar; 9(3):229-36. PubMed ID: 20218848 [No Abstract] [Full Text] [Related]
34. Pneumococcal polysaccharide vaccine efficacy and routine use of conjugate vaccines in infants: there is no need for a vaccine program in older adults at present. Trück J; Lazarus R; Jonsdottir I; Klugman KP; Pollard AJ Clin Infect Dis; 2012 Dec; 55(11):1577-9; author reply 1579-81. PubMed ID: 22903769 [No Abstract] [Full Text] [Related]
35. Memory B Cell Divergences upon Immunization Against Streptococcus pneumoniae in HIV-1-Infected Adults. Tsachouridou O; Skoura L; Zebekakis P; Margariti A; Metallidis S AIDS Res Hum Retroviruses; 2015 Nov; 31(11):1053-4. PubMed ID: 26535799 [No Abstract] [Full Text] [Related]
36. Immunogenicity and safety of pneumococcal conjugate polysaccharide and free polysaccharide vaccines alone or combined in HIV-infected adults in Brazil. Ho YL; Brandão AP; de Cunto Brandileone MC; Lopes MH Vaccine; 2013 Aug; 31(37):4047-53. PubMed ID: 23684823 [TBL] [Abstract][Full Text] [Related]
37. Induction of immunologic memory following primary vaccination with the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine in infants. Knuf M; Pankow-Culot H; Grunert D; Rapp M; Panzer F; Köllges R; Fanic A; Habib A; Borys D; Dieussaert I; Schuerman L Pediatr Infect Dis J; 2012 Jan; 31(1):e31-6. PubMed ID: 21909049 [TBL] [Abstract][Full Text] [Related]
38. Protease Inhibitors Do Not Affect Antibody Responses to Pneumococcal Vaccination. De La Rosa I; Munjal IM; Rodriguez-Barradas M; Yu X; Pirofski LA; Mendoza D Clin Vaccine Immunol; 2016 Jun; 23(6):524-529. PubMed ID: 27074938 [TBL] [Abstract][Full Text] [Related]
39. The effectiveness of pneumococcal polysaccharide vaccination in HIV-infected adults: a systematic review. Pedersen RH; Lohse N; Østergaard L; Søgaard OS HIV Med; 2011 Jul; 12(6):323-33. PubMed ID: 21059168 [TBL] [Abstract][Full Text] [Related]
40. Immunologic non-inferiority and safety of the investigational pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccine (PHiD-CV) 4-dose vial presentation compared to the licensed PHiD-CV 1-dose vial presentation in infants: A phase III randomized study. Zaman K; Zaman SF; Zaman F; Aziz A; Faisal SB; Traskine M; Habib MA; Ruiz-Guiñazú J; Borys D Vaccine; 2018 Jan; 36(5):698-706. PubMed ID: 29277353 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]